Health Minister Greg Hunt said allowing export licences for medicinal cannabis products would improve the viability of domestic producers, thus securing supply for Australian patients.
AusCann's shares soared 53 per cent to $1.26, adding $120 million to company's market value in one day. There were also significant gains on Bod Australia (up 39 per cent), Cann Group (35 per cent), The Hydroponics Company (up 30 per cent), and Creso Pharma (20 per cent).
No comments:
Post a Comment